fda approved

Two oral drugs—approved by the FDA for inflammation in blood diseases (ruxolitinib) and rheumatoid arthritis (tofacitinib)—grow hair when slathered on skin, report surprised Columbia University researchers in Science Advances. If future work supports this, the hair-loss community could have new...

MAPLE GROVE, Minn., June 4, 2014- Upsher-Smith Laboratories, Inc., today announced that it has received final approval from the U.S. Food and Drug Administration (FDA) for its New Drug Application (NDA) for Vogelxo (testosterone) gel for topical use CIII. The company is preparing to launch...